{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:54:57Z","timestamp":1791474897009,"version":"4.3.4"},"reference-count":25,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,9,17]]},"DOI":"10.2967\/jnumed.126.273306","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:20:24Z","timestamp":1791472824000},"page":"jnumed.126.273306","source":"Crossref","is-referenced-by-count":0,"title":["<sup>68<\/sup>\n                    Ga-Labeled Dimeric Cyclic Peptide for Nectin-4\u2013Targeted PET Imaging: From Preclinical Evaluation to First-in-Human Imaging in Breast Cancer"],"prefix":"10.2967","author":[{"given":"Shushan","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingding","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibiao","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2026100808201840000_jnumed.126.273306v1.1","doi-asserted-by":"crossref","first-page":"217681","DOI":"10.1016\/j.canlet.2025.217681","article-title":"Nectin-4 expression patterns and therapeutics in oncology","volume":"622","author":"Nikanjam","year":"2025","journal-title":"Cancer Lett."},{"key":"2026100808201840000_jnumed.126.273306v1.2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1158\/1535-7163.MCT-21-0846","article-title":"The anti-nectin 4: a promising tumor cells target. A systematic review","volume":"21","author":"Blouleftour","year":"2022","journal-title":"Mol Cancer Ther."},{"key":"2026100808201840000_jnumed.126.273306v1.3","doi-asserted-by":"crossref","first-page":"148023","DOI":"10.1016\/j.ijbiomac.2025.148023","article-title":"Membrane glycoprotein nectin-4 in tumor associated pathways and anti-cancer therapeutics","volume":"330","author":"Ganguli","year":"2025","journal-title":"Int J Biol Macromol."},{"key":"2026100808201840000_jnumed.126.273306v1.4","doi-asserted-by":"crossref","first-page":"103838","DOI":"10.1016\/j.breast.2024.103838","article-title":"Targeted therapeutic strategies for nectin-4 in breast cancer: recent advances and future prospects","volume":"79","author":"Wang","year":"2025","journal-title":"Breast."},{"key":"2026100808201840000_jnumed.126.273306v1.5","doi-asserted-by":"crossref","first-page":"e2400766","DOI":"10.1200\/PO-24-00766","article-title":"Assessing nectin-4 as a predictive biomarker in urothelial carcinoma and other genitourinary malignancies","volume":"8","author":"Ozay","year":"2024","journal-title":"JCO Precis Oncol."},{"key":"2026100808201840000_jnumed.126.273306v1.6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pros.24846","article-title":"Nectin-4 expression in prostatic adenocarcinoma: an immunohistochemical study","volume":"85","author":"Baraban","year":"2025","journal-title":"Prostate."},{"key":"2026100808201840000_jnumed.126.273306v1.7","doi-asserted-by":"crossref","first-page":"15900","DOI":"10.3390\/ijms242115900","article-title":"Prognostic potential of nectin expressions in colorectal cancer: an exploratory study","volume":"24","author":"Kobecki","year":"2023","journal-title":"Int J Mol Sci."},{"key":"2026100808201840000_jnumed.126.273306v1.8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1313"},{"key":"2026100808201840000_jnumed.126.273306v1.9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/annonc\/mdw678","article-title":"Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer","volume":"28","author":"M-Rabet","year":"2017","journal-title":"Ann Oncol."},{"key":"2026100808201840000_jnumed.126.273306v1.10","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/cncr.35465","article-title":"PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation","volume":"130","author":"Martini","year":"2024","journal-title":"Cancer."},{"key":"2026100808201840000_jnumed.126.273306v1.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035807.Epub"},{"key":"2026100808201840000_jnumed.126.273306v1.12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1470-2045(25)00158-5","article-title":"Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study","volume":"26","author":"Gupta","year":"2025","journal-title":"Lancet Oncol."},{"key":"2026100808201840000_jnumed.126.273306v1.13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.annonc.2025.04.009","article-title":"Bulumtatug fuvedotin (BFv, 9MW2821), a next-generation nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I\/II study","volume":"36","author":"Zhang","year":"2025","journal-title":"Ann Oncol."},{"key":"2026100808201840000_jnumed.126.273306v1.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4175"},{"key":"2026100808201840000_jnumed.126.273306v1.15","doi-asserted-by":"crossref","first-page":"eady1111","DOI":"10.1126\/sciadv.ady1111","article-title":"Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma","volume":"12","author":"Mishra","year":"2026","journal-title":"Sci Adv."},{"key":"2026100808201840000_jnumed.126.273306v1.16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12951-022-01444-3","article-title":"Nectin-4-targeted immunoSPECT\/CT imaging and photothermal therapy of triple-negative breast cancer","volume":"20","author":"Shao","year":"2022","journal-title":"J Nanobiotechnology."},{"key":"2026100808201840000_jnumed.126.273306v1.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268387"},{"key":"2026100808201840000_jnumed.126.273306v1.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269024"},{"key":"2026100808201840000_jnumed.126.273306v1.19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00259-025-07402-z","article-title":"Rapid and specific immunoPET imaging of nectin-4 in gastric cancer and non-small cell lung cancer using [64Cu]Cu-NOTA-EV-F(ab\u2019)2","volume":"53","author":"Huang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026100808201840000_jnumed.126.273306v1.20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12951-026-04253-0","article-title":"68Ga\/177Lu-labeled nectin4-targeted covalent bicyclic peptide: a novel nectin-4-targeted radioligands for theranostic of urothelial carcinoma","volume":"24","author":"Sun","year":"2026","journal-title":"J Nanobiotechnology."},{"key":"2026100808201840000_jnumed.126.273306v1.21","doi-asserted-by":"crossref","first-page":"21962","DOI":"10.1021\/acs.jmedchem.5c02371","article-title":"\u201cPrecision on Two Wheels\u201d\u2014structural refinement of 64Cu- and 68Ga-labeled bicyclic peptides targeting nectin-4 for improved tumor imaging: from preclinical development to first-in-human application","volume":"68","author":"Kr\u00f6nke","year":"2025","journal-title":"J Med Chem."},{"key":"2026100808201840000_jnumed.126.273306v1.22","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1021\/acs.molpharmaceut.5c01816","article-title":"Covalent versus dimeric optimization of nectin-4-targeted peptide radiotracers: a head-to-head comparison in triple-negative breast cancer mice models","volume":"23","author":"Pei","year":"2026","journal-title":"Mol Pharm."},{"key":"2026100808201840000_jnumed.126.273306v1.23","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s00259-023-06272-7","article-title":"Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides","volume":"50","author":"Millul","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026100808201840000_jnumed.126.273306v1.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-0609"},{"key":"2026100808201840000_jnumed.126.273306v1.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266830"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.273306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:20:29Z","timestamp":1791472829000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.273306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":25,"alternative-id":["10.2967\/jnumed.126.273306"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.273306","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}